Patents by Inventor Miquel Angel GASSULL DURO

Miquel Angel GASSULL DURO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IRSOGLADINE FOR THE TREATMENT OF EOSINOPHILIC GASTROINTESTINAL DISEASES
    Publication number: 20220226333
    Abstract: The present invention provides Irsogladine or a pharmaceutically acceptable salt thereof for use in the treatment and/or prevention of eosinophilic gastrointestinal diseases in mammals. The invention is useful in the treatment of eosinophilic gastritis, eosinophilic gastroenteritis, eosinophilic duodenitis, eosinophilic enteritis, eosinophilic colitis, and in particular, eosinophilic esophagitis. The invention is particularly useful for inducing disease remission in acute inflammatory activity and long-term maintenance of remission as well. The Irsogladine of the invention can be administered in the form of a pharmaceutical composition, or more specifically, in the form of an oral and rectal pharmaceutical composition.
    Type: Application
    Filed: June 5, 2020
    Publication date: July 21, 2022
    Inventors: Daniel GASSULL PALLÀS, Miquel Àngel GASSULL DURÓ
  • METHODS AND REAGENTS FOR EFFICIENT AND TARGETED GENE TRANSFER TO MONOCYTES AND MACROPHAGES
    Publication number: 20150174257
    Abstract: The present invention provides a biosafe and useful vector to transfer genetic material to CD14+ mononuclear cells (monocytes and monocyte-derived macrophages) in an efficient and specific manner. The embodiment of the invention makes use of the chimeric human adenovirus vectors 5 carrying the short fiber of enterotropic Ad40 to transfer genetic material to the target CD14+ mononuclear cells.
    Type: Application
    Filed: March 3, 2015
    Publication date: June 25, 2015
    Inventors: Miquel Angel GASSULL DURO, Adolfo RIO FERNANDEZ, Ester FERNANDEZ GIMENO, Miguel CHILLON RODRIGUEZ
  • METHODS AND REAGENTS FOR EFFICIENT AND TARGETED GENE TRANSFER TO MONOCYTES AND MACROPHAGES
    Publication number: 20120045389
    Abstract: The present invention provides a biosafe and useful vector to transfer genetic material to CD14+ mononuclear cells (monocytes and monocyte-derived macrophages) in an efficient and specific manner. The embodiment of the invention makes use of the chimeric human adenovirus vectors 5 carrying the short fiber of enterotropic Ad40 to transfer genetic material to the target CD14+ mononuclear cells.
    Type: Application
    Filed: April 28, 2010
    Publication date: February 23, 2012
    Applicants: UNIVERSITAT AUTÒNOMA DE BARCELONA, FUNDACIÓ PRIVADA INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANCATS, FUNDACIÓ INSTITUT D'INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL, GRIFOLS, S.A.
    Inventors: Miquel Àngel Gassull Duro, Adolfo Rio Fernandez, Ester Fernandez Gimeno, Miguel Chillón Rodriguez